Malignant tumours after renal transplantation.
In 1243 patients after renal transplantation, 39 malignant tumours were detected in 37 patients. The average latency period between transplantation and tumour disease was 72 months. Tumours included 8 malignant lymphomas, 7 dermatomas and 24 visceral tumours. The patients who developed a tumour had received fewer blood transfusions before transplantation than a tumour-free control group of 60 patients with renal transplants. Rejection crises occurred in a significantly smaller number of tumour patients compared with the control group.
Fahlenkamp
D
D
Department of Urology, Charité Hospital, Medical School, Humboldt University Berlin.
Reinke
P
P
Kirchner
S
S
Schnorr
D
D
Lindeke
A
A
Loening
S A
SA
D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D011183:Postoperative Complications; D011239:Prednisolone / Q000008:administration & dosage; D012306:Risk
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone